PUBLISHER: IMARC | PRODUCT CODE: 1702202
PUBLISHER: IMARC | PRODUCT CODE: 1702202
The global artificial cornea and corneal implant market size was valued at USD 468.85 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 831.98 Million by 2033, exhibiting a CAGR of 6.25% during 2025-2033. North America currently dominates the market with a market share of 50.5%. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.
Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases. Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.
At present, the increasing demand for artificial cornea and corneal implants due to the rising prevalence of corneal infections and eye-associated disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing construction of various healthcare facilities, such as hospitals, nursing homes, and eye clinics, to provide effective treatment to patients is offering a favorable market outlook. In addition, the rising occurrence of eyesight complications among young individuals for spending prolonged hours looking at smartphones or working on computers and laptops is propelling the growth of the market. Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays. This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.